ATC codes: H02AB02
Allergic or hypersensitivity conditions of unspecified type ICD11 code: 4A8Z
Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosphate salt)
Also recommended for children
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
The EMLc Subcommittee endorsed the inclusion of dexamethasone on the core list of the EMLc for severe allergic reactions. In consideration of the need for corticosteroids for allergic disorders in children, the EMLc Subcommittee noted that dexamethasone injection was licensed for use in allergic disorders in children in some countries and is also used for non-allergic disorders, such as cerebral oedema, croup, post-operative nausea and vomiting and in the treatment of bacterial meningitis. while recognizing the need for systemic steroids in severe allergic reactions, the Subcommittee noted that for conditions such as allergic rhinitis and conjunctivitis, topical steroids or topical antihistamines have been shown to be effective and safer.